Epidermal growth factor receptor endocytic traffic perturbation by phosphatidate phosphohydrolase inhibition: New strategy against cancer

Medicine and Dentistry

• Malignant Neoplasm 100%
• Epidermal Growth Factor Receptor 100%
• Phosphatidate Phosphatase 100%
• Phosphatase 52%
• Cell Proliferation 17%
• Lifespan 11%
• Receptor 11%
• Endosome 11%
• Endocytosis 11%
• Rolipram 11%
• Phosphatidic Acid 11%
• Propranolol 11%
• Programmed Cell Death 5%
• Cancer 5%
• Cancer Therapy 5%
• Tyrosine-Kinase Inhibitor 5%
• Cancer Cell Line 5%
• Protein Tyrosine Kinase 5%
• Cyclic AMP Dependent Protein Kinase 5%
• Ligand Binding 5%
• Anchorage Independent Growth 5%
• Internalization 5%
• Desipramine 5%
• Phosphodiesterase IV Inhibitor 5%
• Phospholipase D 5%
• Phosphodiesterase 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Epidermal Growth Factor Receptor 100%
• Phosphatidate Phosphatase 100%
• Phosphatase 52%
• Propranolol 11%
• Rolipram 11%
• Receptor 11%
• Phosphatidic Acid 11%
• Protein Tyrosine Kinase Inhibitor 5%
• Protein Tyrosine Kinase 5%
• Desipramine 5%
• Cyclic AMP Dependent Protein Kinase 5%
• Phosphodiesterase IV Inhibitor 5%
• Phosphodiesterase 5%
• Phospholipase D 5%

Biochemistry, Genetics and Molecular Biology

• Phosphatidate Phosphatase 100%
• Epidermal Growth Factor Receptor 100%
• Cell Proliferation 17%
• Phosphatidic Acid 11%
• Lifespan 11%
• Endocytosis 11%
• Eicosanoid Receptor 11%
• Propranolol 11%
• Tyrosine Kinase Inhibitor 5%
• Ligand Binding 5%
• Tyrosine Kinase 5%
• Cancer Cell 5%
• Phosphodiesterase 5%
• Phospholipase D 5%
• Internalization 5%
• Receptor Tyrosine Kinase 5%
• Protein Kinase A 5%
• Anchorage Independent Growth 5%